Phase 2 Readout~quarter

Phase 2 Readout: olvi-vec

Indication
VIRO-25 trial

Other upcoming events for GNLX

Phase 3 ReadoutPhase 3 Topline: A Randomized Phase 3 Study Assessing the Efficacy and Safety of Olvi-Vec Followed by Platinum-double

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 2 Readout: olvi-vec — GNLX Phase 2 Readout | BioSniper